The White House is taking steps to kill the FDA reform legislation recently passed in the House of Representatives that would require drug companies to publicly post clinical trial results so that doctors, researchers and the public could review them. According to a report in Inside Health Policy, the White House sent congressional staff an "unofficial statement of administration policy" that opposes this provision in the House bill. The blocking of this provision would allow drug companies to continue to conduct their clinical trials in secret, hiding results from the public and cherry picking only those clinical trials they wish to make public.
http://www.newstarget.com/022045.htmlFriday, Sept. 14, 2007
Reported White House Opposition to Making Drug Trial Results Public Would allow Pharmaceutical Companies to Hide Safety Problems
Congress must make sure accurate, public drug trials are in final reform bill
(Washington, DC) – A press report that the White House is opposing a major provision in the FDA reform legislation requiring drug companies make public their clinical trial results would be shocking and disappointing if true, Consumers Union said today. Failing to make such information public would allow drug makers to hide safety problems with their products.
“If this is truly the administration’s position, it’s shocking,” said Bill Vaughan, senior health policy analyst with Consumers Union, publisher of Consumer Reports. “At a time when parents can’t even trust their kids’ toys to be safe, it doesn’t make sense the White House would oppose legislation to help make prescription drugs safer.”
more at link
http://www.consumersunion.org/pub/campaignprescriptionforchange/004889.html